Coeptis Therapeutics Holdings, Inc. Announces Pricing Of $3.5M Underwritten Offering
Portfolio Pulse from Benzinga Newsdesk
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) announced the pricing of a $3.5 million underwritten offering to a single healthcare-focused investor. The offering includes common stock, pre-funded warrants, and Series A and B warrants. Ladenburg Thalmann & Co. Inc. is the sole book-running manager.
June 14, 2023 | 1:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Coeptis Therapeutics' $3.5 million underwritten offering may provide the company with additional capital for growth and development.
The underwritten offering will provide Coeptis Therapeutics with additional capital, which can be used for growth and development. This may have a positive impact on the company's stock price in the short term as it demonstrates investor confidence and provides resources for expansion.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100